Aspergillosis is a common fungal infection that affects both humans and animals. While it can be treated with antifungal medications, there is an increasing need for new treatments as the infection is becoming more resistant to existing treatments. This article explores the new treatments for aspergillosis, including both conventional and novel therapies.
Conventional Therapies
Conventional treatments for aspergillosis include antifungal medications, such as voriconazole and itraconazole. These medications are used to kill the fungal cells and prevent the spread of the infection. Other conventional therapies include topical creams and ointments, as well as surgery to remove infected tissue.
Novel Therapies
Novel therapies for aspergillosis are being developed and tested. These include the use of probiotics, which are beneficial bacteria that can help to restore the balance of the immune system and reduce the risk of infection. Other novel therapies include the use of nanoparticles to deliver antifungal medications directly to the site of infection. Finally, there is research being conducted into the use of stem cells to treat aspergillosis.
Conclusion
Aspergillosis is a common fungal infection that can be difficult to treat. There is an increasing need for new treatments as existing treatments become less effective. Conventional treatments include antifungal medications and topical creams, while novel therapies are being developed and tested. These include the use of probiotics, nanoparticles and stem cells.